CERE — Cerevel Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00Cerevel Therapeutics Holdings Inc expected to post a loss of 67 cents a share - Earnings Preview
Karuna Therapeutics falls on hypertension concerns for schizophrenia drug
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, gold miners, FedEx Corp
U.S. STOCKS ON THE MOVE-Traeger, Range Resources, U.S. banks
Cerevel falls after J.P. Morgan downgrades to 'neutral'
U.S. STOCKS ON THE MOVE-First Republic Bank, Acer Therapeutics, Baidu
U.S. STOCKS ON THE MOVE-FedEx, Enzo Biochem, crypto stocks
JP Morgan downgrades Cerevel to 'neutral' citing few near-term catalysts
Cerevel Therapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Cerevel Therapeutics Posts Q4 Net Loss $92.808 Million
Cerevel Therapeutics Holdings Inc expected to post a loss of 64 cents a share - Earnings Preview
Brief: Cerevel Therapeutics To Present At 41St Annual J.P. Morgan Healthcare Conference And Provide Pipeline Update
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Cerevel jumps as schizophrenia treatment shows promise in trial
Brief: Cerevel Therapeutics Announces Positive Results In Emraclidine Ambulatory Blood Pressure Monitoring Trial
U.S. RESEARCH ROUNDUP- Amgen, Equitable Holdings, Royal Caribbean
U.S. RESEARCH ROUNDUP-Amyris, HanesBrands, Roblox
Brief: Cerevel Therapeutics Reports Third Quarter Financial Results
U.S. STOCKS ON THE MOVE-Digital World Acquisition, Carnival, Crypto stocks